ArticleIJU case reports2025
Mixed Epithelial and Stromal Tumor of the Kidney in a Patient With Mental Retardation: A Case Report.
Article in IJU case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Mixed epithelial and stromal tumors are rare renal neoplasms. Case Presentation: A 55-year-old woman with mental retardation presented with a giant renal tumor with abdominal pain. After a renal biopsy with a definitive diagnosis, an open total nephrectomy was performed. There was no recurrence for the following year. Clinical Discussion: Since a definitive diagnosis of MEST cannot be made through imaging alone, surgery is the preferred diagnostic treatment. To our knowledge, renal biopsy has only been reported in three cases. There are only two reports of nonsurgical treatment of benign MEST and no reports of malignant transformation or exacerbation. Conclusion: If the biopsy findings are suggestive of a benign tumor, follow-up is an option. We look forward to reporting the long-term outcomes of the conservative management of MEST.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.